An intrabody targeting PHD2 protects mice against acetaminophen-induced liver injury by attenuating ferroptosis

Ze Ren1, Ying Wang1, Cheng Cheng1

  • 1Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.

PubMed

Insights

A novel intrabody targeting prolyl hydroxylase 2 (PHD2) protects against acetaminophen-induced liver injury by inhibiting ferroptosis. This approach restores redox balance and enhances glutathione synthesis, offering a new therapeutic strategy.

Area of Science:

  • Biochemistry
  • Hepatology
  • Molecular Biology

Background:

  • Acetaminophen overdose is a leading cause of acute liver failure, with ferroptosis playing a key role.
  • The prolyl hydroxylase 2 (PHD2)/hypoxia-inducible factor-1α (HIF-1α) axis is implicated in acetaminophen-induced liver injury (AILI), but its role in ferroptosis is unclear.

Purpose of the Study:

  • To develop a novel anti-PHD2 intrabody (INP2) and investigate its mechanism in preventing AILI by targeting ferroptosis.
  • To elucidate how INP2 regulates the PHD2/HIF-1α axis and its downstream effects on ferroptosis and hepatoprotection.

Main Methods:

  • Development of a cytoplasmic intrabody (INP2) targeting PHD2.
  • Assessment of INP2's effect on PHD2/HIF-1α interaction, HIF-1α stability, and ferroptosis markers in vitro and in a murine AILI model.
  • Investigation of INP2's impact on redox homeostasis, glutathione biosynthesis, and the expression of SLC7A11 and glutathione peroxidase 1 (GPX1).

Main Results:

  • INP2 specifically recognized PHD2, disrupted its interaction with HIF-1α, and increased HIF-1α stability.
  • INP2 pretreatment significantly protected against AILI by attenuating ferroptosis, restoring redox homeostasis, and reducing oxidative stress markers.
  • INP2 upregulated SLC7A11 and GPX1, enhancing glutathione biosynthesis and decreasing hepatocyte cytotoxicity; GPX1 knockdown impaired INP2's protective effects.

Conclusions:

  • A PHD2-targeted intrabody (INP2) effectively protects against acetaminophen-induced liver injury by attenuating ferroptosis.
  • The mechanism involves regulating the PHD2/HIF-1α/GPX1 axis, which enhances glutathione synthesis and suppresses oxidative stress.
  • INP2 represents a promising therapeutic strategy for preventing and treating acetaminophen-induced liver injury.